COVID-19 rapid test Convergys®
for nucleocapsid proteinsSARS-COV-2nasopharyngeal

COVID-19 rapid test
COVID-19 rapid test
Add to favorites
Compare this product
 

Characteristics

Applications
COVID-19
Tested parameter
for nucleocapsid proteins
Micro-organism
SARS-COV-2
Sample type
nasopharyngeal, nasal
Analysis mode
chromatographic immunoassay
Result display time

15 min

Specificity

99 %

Sensitivity

95 %

Description

The Convergys® COVID-19 Rapid Antigen Test is designed for the direct testing for acute COVID-19 infections. The rapid chromatographic immunoassay detects the Nucleocapsid protein of SARS-CoV-2, the pathogen causing the COVID-19 disease. Results are available in 15 minutes. The test kit works with nasopharyngeal and nasal patient swabs and includes all required materials for collecting the sample and doing the test. It can be stored at room temperature and the shelf life is 24 months. The Convergys® COVID-19 Rapid Antigen Test is offically listed by the German Federal Institute for Drugs and Medical Devices (BfArM ID: AT498/20).
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.